{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MBNL1", "RNA splicing", "RNA-protein interaction", "alkaloids", "myotonic dystrophy", "natural product", "non-coding RNA", "trinucleotide repeat disease"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27298317", "DateCompleted": {"Year": "2017", "Month": "05", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "02", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "06", "Day": "13"}], "ELocationID": ["10.1074/jbc.M115.710616"], "Language": ["eng"], "Journal": {"ISSN": "1083-351X", "JournalIssue": {"Volume": "291", "Issue": "33", "PubDate": {"Year": "2016", "Month": "Aug", "Day": "12"}}, "Title": "The Journal of biological chemistry", "ISOAbbreviation": "J Biol Chem"}, "ArticleTitle": "Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.", "Pagination": {"StartPage": "17165", "EndPage": "17177", "MedlinePgn": "17165-77"}, "Abstract": {"AbstractText": ["Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide repeats in the 3' UTR of the dystrophia myotonica protein kinase gene. On the RNA level, expanded (CUG)n repeats form hairpin structures that sequester splicing factors such as muscleblind-like 1 (MBNL1). Lack of available MBNL1 leads to misregulated alternative splicing of many target pre-mRNAs, leading to the multisystemic symptoms in DM1. Many studies aiming to identify small molecules that target the (CUG)n-MBNL1 complex focused on synthetic molecules. In an effort to identify new small molecules that liberate sequestered MBNL1 from (CUG)n RNA, we focused specifically on small molecules of natural origin. Natural products remain an important source for drugs and play a significant role in providing novel leads and pharmacophores for medicinal chemistry. In a new DM1 mechanism-based biochemical assay, we screened a collection of isolated natural compounds and a library of over 2100 extracts from plants and fungal strains. HPLC-based activity profiling in combination with spectroscopic methods were used to identify the active principles in the extracts. The bioactivity of the identified compounds was investigated in a human cell model and in a mouse model of DM1. We identified several alkaloids, including the \u03b2-carboline harmine and the isoquinoline berberine, that ameliorated certain aspects of the DM1 pathology in these models. Alkaloids as a compound class may have potential for drug discovery in other RNA-mediated diseases."], "CopyrightInformation": "\u00a9 2016 by The American Society for Biochemistry and Molecular Biology, Inc."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and."}], "LastName": "Herrendorff", "ForeName": "Ruben", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "the Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland."}], "LastName": "Faleschini", "ForeName": "Maria Teresa", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and."}], "LastName": "Stiefvater", "ForeName": "Adeline", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and."}], "LastName": "Erne", "ForeName": "Beat", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and."}], "LastName": "Wiktorowicz", "ForeName": "Tatiana", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and."}], "LastName": "Kern", "ForeName": "Frances", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "the Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland."}], "LastName": "Hamburger", "ForeName": "Matthias", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "the Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland."}], "LastName": "Potterat", "ForeName": "Olivier", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and j.kinter@unibas.ch."}], "LastName": "Kinter", "ForeName": "Jochen", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Neuromuscular Research Group, Departments of Neurology and Biomedicine, University Hospital Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland and michael.sinnreich@unibas.ch."}], "LastName": "Sinnreich", "ForeName": "Michael", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Biol Chem", "NlmUniqueID": "2985121R", "ISSNLinking": "0021-9258"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3' Untranslated Regions"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "MBNL1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Mbnl1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA-Binding Proteins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "3' Untranslated Regions"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Alternative Splicing"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Myotonic Dystrophy"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "Trinucleotide Repeat Expansion"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Machuca-Tzili L., Brook D., and Hilton-Jones D. (2005) Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 32, 1\u201318", "ArticleIdList": ["15770660"]}, {"Citation": "Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcel\u00f3 J., and O'Hoy K. (1992) Myotonic-dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene. Science 255, 1253\u20131255", "ArticleIdList": ["1546325"]}, {"Citation": "Brook J. D., McCurrach M. E., Harley H. G., Buckler A. J., Church D., Aburatani H., Hunter K., Stanton V. P., Thirion J. P., and Hudson T. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell 69, 385\u2013385", "ArticleIdList": ["1568252"]}, {"Citation": "Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., and Thornton C. A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769\u20131773", "ArticleIdList": ["10976074"]}, {"Citation": "Wheeler T. M., Sobczak K., Lueck J. D., Osborne R. J., Lin X., Dirksen R. T., and Thornton C. A. (2009) Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336\u2013339", "ArticleIdList": ["PMC4109973", "19608921"]}, {"Citation": "Taneja K. L., McCurrach M., Schalling M., Housman D., and Singer R. H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic-dystrophy cells and tissues. J. Cell Biol. 128, 995\u20131002", "ArticleIdList": ["PMC2120416", "7896884"]}, {"Citation": "Davis B. M., McCurrach M. E., Taneja K. L., Singer R. H., and Housman D. E. (1997) Expansion of a CUG trinucleotide repeat in the 3\u2032 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. U.S.A. 94, 7388\u20137393", "ArticleIdList": ["PMC23831", "9207101"]}, {"Citation": "Miller J. W., Urbinati C. R., Teng-Umnuay P., Stenberg M. G., Byrne B. J., Thornton C. A., and Swanson M. S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439\u20134448", "ArticleIdList": ["PMC302046", "10970838"]}, {"Citation": "Yuan Y., Compton S. A., Sobczak K., Stenberg M. G., Thornton C. A., Griffith J. D., and Swanson M. S. (2007) Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35, 5474\u20135486", "ArticleIdList": ["PMC2018611", "17702765"]}, {"Citation": "Philips A. V., Timchenko L. T., and Cooper T. A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737\u2013741", "ArticleIdList": ["9563950"]}, {"Citation": "Lin X., Miller J. W., Mankodi A., Kanadia R. N., Yuan Y., Moxley R. T., Swanson M. S., and Thornton C. A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087\u20132097", "ArticleIdList": ["16717059"]}, {"Citation": "Mankodi A., Takahashi M. P., Jiang H., Beck C. L., Bowers W. J., Moxley R. T., Cannon S. C., and Thornton C. A. (2002) Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35\u201344", "ArticleIdList": ["12150905"]}, {"Citation": "Charlet-B N., Savkur R. S., Singh G., Philips A. V., Grice E. A., and Cooper T. A. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45\u201353", "ArticleIdList": ["12150906"]}, {"Citation": "Savkur R. S., Philips A. V., and Cooper T. A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40\u201347", "ArticleIdList": ["11528389"]}, {"Citation": "Hino S., Kondo S., Sekiya H., Saito A., Kanemoto S., Murakami T., Chihara K., Aoki Y., Nakamori M., Takahashi M. P., and Imaizumi K. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet. 16, 2834\u20132843", "ArticleIdList": ["17728322"]}, {"Citation": "Ho T. H., Charlet-B N., Poulos M. G., Singh G., Swanson M. S., and Cooper T. A. (2004) Muscleblind proteins regulate alternative splicing. EMBO J. 23, 3103\u20133112", "ArticleIdList": ["PMC514918", "15257297"]}, {"Citation": "Berg J., Jiang H., Thornton C. A., and Cannon S. C. (2004) Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current. Neurology 63, 2371\u20132375", "ArticleIdList": ["15623702"]}, {"Citation": "Krzyzosiak W. J., Sobczak K., Wojciechowska M., Fiszer A., Mykowska A., and Kozlowski P. (2012) Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res. 40, 11\u201326", "ArticleIdList": ["PMC3245940", "21908410"]}, {"Citation": "Lee J. E., Bennett C. F., and Cooper T. A. (2012) RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc. Natl. Acad. Sci. U.S.A. 109, 4221\u20134226", "ArticleIdList": ["PMC3306674", "22371589"]}, {"Citation": "Kanadia R. N., Shin J., Yuan Y., Beattie S. G., Wheeler T. M., Thornton C. A., and Swanson M. S. (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. U.S.A. 103, 11748\u201311753", "ArticleIdList": ["PMC1544241", "16864772"]}, {"Citation": "Warf M. B., Nakamori M., Matthys C. M., Thornton C. A., and Berglund J. A. (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl. Acad. Sci. U.S.A. 106, 18551\u201318556", "ArticleIdList": ["PMC2774031", "19822739"]}, {"Citation": "Arambula J. F., Ramisetty S. R., Baranger A. M., and Zimmerman S. C. (2009) A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc. Natl. Acad. Sci. U.S.A. 106, 16068\u201316073", "ArticleIdList": ["PMC2752522", "19805260"]}, {"Citation": "Pushechnikov A., Lee M. M., Childs-Disney J. L., Sobczak K., French J. M., Thornton C. A., and Disney M. D. (2009) Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J. Am. Chem. Soc. 131, 9767\u20139779", "ArticleIdList": ["PMC2731475", "19552411"]}, {"Citation": "Childs-Disney J. L., Hoskins J., Rzuczek S. G., Thornton C. A., and Disney M. D. (2012) Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive. ACS Chem. Biol. 7, 856\u2013862", "ArticleIdList": ["PMC3356481", "22332923"]}, {"Citation": "Gareiss P. C., Sobczak K., McNaughton B. R., Palde P. B., Thornton C. A., and Miller B. L. (2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J. Am. Chem. Soc. 130, 16254\u201316261", "ArticleIdList": ["PMC2645920", "18998634"]}, {"Citation": "Ofori L. O., Hoskins J., Nakamori M., Thornton C. A., and Miller B. L. (2012) From dynamic combinatorial \u201chit\u201d to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy. Nucleic Acids Res. 40, 6380\u20136390", "ArticleIdList": ["PMC3401475", "22492623"]}, {"Citation": "Hoskins J. W., Ofori L. O., Chen C. Z., Kumar A., Sobczak K., Nakamori M., Southall N., Patnaik S., Marugan J. J., Zheng W., Austin C. P., Disney M. D., Miller B. L., and Thornton C. A. (2014) Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects. Nucleic Acids Res. 42, 6591\u20136602", "ArticleIdList": ["PMC4041448", "24799433"]}, {"Citation": "Chen C. Z., Sobczak K., Hoskins J., Southall N., Marugan J. J., Zheng W., Thornton C. A., and Austin C. P. (2012) Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1. Anal. Bioanal. Chem. 402, 1889\u20131898", "ArticleIdList": ["PMC3280409", "22218462"]}, {"Citation": "Koehn F. E., and Carter G. T. (2005) The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4, 206\u2013220", "ArticleIdList": ["15729362"]}, {"Citation": "Wilson D. N. (2014) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol. 12, 35\u201348", "ArticleIdList": ["24336183"]}, {"Citation": "Chaouch S., Mouly V., Goyenvalle A., Vulin A., Mamchaoui K., Negroni E., Di Santo J., Butler-Browne G., Torrente Y., Garcia L., and Furling D. (2009) Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells. Hum. Gene Ther. 20, 784\u2013790", "ArticleIdList": ["19358679"]}, {"Citation": "Potterat O., and Hamburger M. (2014) Combined use of extract libraries and HPLC-based activity profiling for lead discovery: potential, challenges, and practical considerations. Planta Med. 80, 1171\u20131181", "ArticleIdList": ["25098928"]}, {"Citation": "Mykowska A., Sobczak K., Wojciechowska M., Kozlowski P., and Krzyzosiak W. J. (2011) CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res. 39, 8938\u20138951", "ArticleIdList": ["PMC3203611", "21795378"]}, {"Citation": "Kumar G. S. (2012) RNA targeting by small molecules: binding of protoberberine, benzophenanthridine and Aristolochia alkaloids to various RNA structures. J. Biosci. 37, 539\u2013552", "ArticleIdList": ["22750990"]}, {"Citation": "Nafisi S., Malekabady Z. M., and Khalilzadeh M. A. (2010) Interaction of \u03b2-carboline alkaloids with RNA. DNA Cell Biol. 29, 753\u2013761", "ArticleIdList": ["20731607"]}, {"Citation": "Islam M. M., Chowdhury S. R., and Kumar G. S. (2009) Spectroscopic and calorimetric studies on the binding of alkaloids berberine, palmatine and coralyne to double stranded RNA polynucleotides. J. Phys. Chem. B 113, 1210\u20131224", "ArticleIdList": ["19132839"]}, {"Citation": "Cetinkol O. P., and Hud N. V. (2009) Molecular recognition of poly(A) by small ligands: an alternative method of analysis reveals nanomolar, cooperative and shape-selective binding. Nucleic Acids Res. 37, 611\u2013621", "ArticleIdList": ["PMC2632892", "19073699"]}, {"Citation": "Thomas J. R., and Hergenrother P. J. (2008) Targeting RNA with small molecules. Chem. Rev. 108, 1171\u20131224", "ArticleIdList": ["18361529"]}, {"Citation": "Warf M. B., and Berglund J. A. (2007) MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA 13, 2238\u20132251", "ArticleIdList": ["PMC2080590", "17942744"]}, {"Citation": "Turner N., Li J.-Y., Gosby A., To S. W., Cheng Z., Miyoshi H., Taketo M. M., Cooney G. J., Kraegen E. W., James D. E., Hu L.-H., Li J., and Ye J.-M. (2008) Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57, 1414\u20131418", "ArticleIdList": ["18285556"]}, {"Citation": "Jiang J.-F., Wang Y.-G., Hu J., Lei F., Kheir M. M., Wang X.-P., Chai Y.-S., Yuan Z.-Y., Lu X., Xing D.-M., Du F., and Du L.-J. (2013) Novel effect of berberine on thermoregulation in mice model induced by hot and cold environmental stimulation. PLoS ONE 10.1371/journal.pone.0054234", "ArticleIdList": ["10.1371/journal.pone.0054234", "PMC3545878", "23335996"]}, {"Citation": "Guan Y. B., Louis E. D., and Zheng W. (2001) Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J. Toxicol. Env. Health A 64, 645\u2013660", "ArticleIdList": ["PMC4992346", "11766171"]}, {"Citation": "Lee S. S., Kai M., and Lee M. K. (1999) Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: inhibition by berberine and palmatine. Med. Sci. Res. 27, 749\u2013751"}, {"Citation": "Herraiz T., Gonz\u00e1lez D., Anc\u00edn-Azpilicueta C., Ar\u00e1n V. J., and Guill\u00e9n H. (2010) \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem. Toxicol. 48, 839\u2013845", "ArticleIdList": ["20036304"]}, {"Citation": "Dimauro I., Pearson T., Caporossi D., and Jackson M. J. (2012) A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res. Notes 5, 513\u2013513", "ArticleIdList": ["PMC3508861", "22994964"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "14"}, {"Year": "2016", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27298317", "PMC5016119", "10.1074/jbc.M115.710616", "S0021-9258(20)33458-X"]}}], "PubmedBookArticle": []}